NCT02810600View on ClinicalTrials.gov

Study to Measure the Safety of 68Ga-DOTA-TATE PET/CT in the Diagnosis of Tumors Expressing Somatostatin Receptors

CompletedOBSERVATIONAL

Enrollment

2,120

Participants

Timeline

Start Date

June 8, 2016

Primary Completion Date

January 1, 2020

Study Completion Date

May 29, 2020

Conditions

Neuroendocrine Tumors

Interventions

OTHER

Gallium-68 DOTA TATE PET scan

One PET/CT scan using Gallium-68 DOTA TATE

Trial Locations (1)

J1H 5N4

Centre hospitalier universitaire de Sherbrooke, Sherbrooke

All Listed Sponsors

lead

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

OTHER

NCT02810600 - Study to Measure the Safety of 68Ga-DOTA-TATE PET/CT in the Diagnosis of Tumors Expressing Somatostatin Receptors | Biotech Hunter | Biotech Hunter